Haemonetics to Present at The Raymond James Institutional Investors Conference

News provided by

Feb 25, 2013, 08:00 ET

BRAINTREE, Mass., Feb. 25, 2013 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Brian Concannon, President & CEO, will present at The Raymond James Institutional Investors Conference in Orlando, Florida on March 6, 2013 at 8:40am Eastern time.

(Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO)

The public may access Mr. Concannon's presentation live via webcast at http://wsw.com/webcast/rj82/hae/.

About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.

CONTACT:
Gerry Gould, VP-Investor Relations
Tel. (781) 356-9402
[email protected]
Alt. (781) 356-9613

SOURCE Haemonetics Corporation